|Bid||256.00 x 800|
|Ask||267.77 x 1000|
|Day's Range||262.74 - 268.13|
|52 Week Range||177.70 - 301.34|
|Beta (5Y Monthly)||0.30|
|PE Ratio (TTM)||85.49|
|Earnings Date||Oct 27, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||1.56 (0.57%)|
|Ex-Dividend Date||May 12, 2021|
|1y Target Est||261.67|
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strong customer demand and new product launches are likely to contribute to growth in the fiscal first quarter for ResMed (RMD).
In this article we will check out the progression of hedge fund sentiment towards ResMed Inc. (NYSE:RMD) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 […]